Company Filing History:
Years Active: 2001-2009
Title: Nicola Jane Camp: Innovator in Human Genetics
Introduction
Nicola Jane Camp is a notable inventor based in Salt Lake City, UT (US). She has made significant contributions to the field of human genetics, particularly in understanding the genetic predisposition to depression. With a total of three patents to her name, her work has the potential to impact both diagnostics and therapeutics in mental health.
Latest Patents
One of her latest patents focuses on the identification of a human depression predisposing gene, specifically the apoptotic protease activating factor 1 (APAF1) gene. This invention relates to methods and materials used to isolate and detect mutations in the APAF1 gene that may cause susceptibility to depression. It also addresses the prophylaxis and therapy of depression associated with these mutations. Another significant patent involves diagnostics and therapeutics for diseases associated with an IL-1 inflammatory haplotype. This patent provides methods and kits for determining whether a subject has or is predisposed to developing diseases linked to IL-1 polymorphisms, along with assays for identifying potential therapeutics.
Career Highlights
Throughout her career, Nicola has worked with reputable organizations such as Interleukin Genetics, Inc. and IHC Health Services. Her experience in these companies has allowed her to further her research and contribute to advancements in genetic diagnostics and therapies.
Collaborations
Nicola has collaborated with notable colleagues, including Gordon W. Duff and Angela Cox. These partnerships have enriched her research and expanded the impact of her inventions in the field of genetics.
Conclusion
Nicola Jane Camp's innovative work in human genetics, particularly regarding depression, showcases her dedication to advancing medical science. Her patents not only enhance our understanding of genetic predispositions but also pave the way for new therapeutic approaches.